Prevalence of Dyslipidemia in Undiagnosed Palestinian Men: A Cross-Sectional Study

Table 2

Dyslipidemia prevalence in the participant based on laboratory results and the adult treatment panel (ATP III criteria).

Fasting lipoprotein levels based on ATP III		Level (mg/dL)	Frequency ()	Valid (%)	Cumulative (%)
TC	Desirable	<200	97	69.3	69.3
	Borderline high	200–239	38	27.1	96.4
	High	≥240	5	3.6	100
LDL	Optimal	<100	34	24.3	24.3
	Above optimal	100–129	51	36.4	60.7
	Borderline high	130–159	43	30.7	91.4
	High	160–189	10	7.1	98.6
	Very high	≥190	2	1.4	100
HDL	Low	<40	83	59.3	59.3
	Normal	40–59	53	37.9	97.1
	High	≥60	4	2.9	100
TG	Normal	<150	77	55	55
	Borderline high	150–199	35	25	80
	High	200–490	27	19.3	99.3
	Very high	≥500	1	0.7	100